ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Clinical trial NCT05949684 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05949684
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2028-03-24
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.